Pulmonx Investor Relations Material
Latest events
Q1 2025
Pulmonx
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Pulmonx Corporation
Access all reports
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company markets airway clearance therapy systems used to administer medications and mucus-thinning agents to treat cystic fibrosis and other respiratory conditions. Its products include Pulmonx System for Lungs, Lung Flute device, and Combyn device that are used in the subglottic suctioning of mucus from the upper part of the lungs. Pulmonx Corporation was founded in 1995 and is headquartered in Redwood City, California.
Key slides for Pulmonx Corporation
Investor Presentation
Pulmonx Corporation
Investor Presentation
Pulmonx Corporation
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
LUNG
Country
🇺🇸 United States